S. 415 · 117th Congress
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity.
- Stage
- Signed by the president
- Sponsor
- Bill Cassidy
- Introduced
- 2021-02-24
- Latest action
- 2021-04-23 · Signed by President.
Action history
- 2021-04-23Signed by President.
- 2021-04-23Became Public Law No: 117-9.
- 2021-04-20Presented to President.
- 2021-04-14Motion to reconsider laid on the table Agreed to without objection.
- 2021-04-14On motion to suspend the rules and pass the bill Agreed to by voice vote.
- 2021-04-14DEBATE - The House proceeded with forty minutes of debate on S. 415.
- 2021-04-14Considered under suspension of the rules.
- 2021-04-14Mr. Pallone moved to suspend the rules and pass the bill.
- 2021-03-12Held at the desk.
- 2021-03-12Received in the House.
- 2021-03-11Message on Senate action sent to the House.
- 2021-03-10Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
- 2021-03-10Passed Senate without amendment by Unanimous Consent.
- 2021-02-24Introduced in Senate
- 2021-02-24Read twice and referred to the Committee on Health, Education, Labor, and Pensions.